CareDx, Inc. · 1 day ago
Medical Science Liaison - Los Angeles or San Francisco
California
Full-time
Onsite
Mid, Senior Level
$110K/yr - $170K/yr
3+ years expCareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients. The Medical Science Liaison (MSL) will educate physicians and transplant coordinators about the clinical value of the AlloMap and AlloSure tests, while providing clinical support and developing relationships with key opinion leaders in the field.
BiotechnologyHealth CareHealth DiagnosticsInformation Technology
Responsibilities
Communicate and reinforce the clinical utility of the AlloMap and AlloSure tests
Develop strong and productive working relationships with key opinion leaders (KOLs) in the field of transplantation
Help analyze, interpret, and clarify AlloMap and AlloSure test results in conjunction with other clinical data
Provide on-site clinical support at transplant centers through oral presentations, test result data reviews and interactive resolution of clinician queries
Function as the primary clinical resource for the Transplant Account Manager (TAM) team to support product adoption and expanded use of CareDx products
Assist new product development teams in defining unmet needs, product performance requirements, and launch plans
Provide clinical support for Customer Service inquiries and complaints
Participate in Medical Advisory Board meetings with KOLs
Participate in Clinical Workshop meetings with KOLs
Support company initiatives at clinical and scientific meetings
Function as a clinical liaison and resource to payer and insurance groups
Support Clinical Operations as needs with field support at transplant centers participating in CareDx sponsored trials
Qualification
Required
Health care professionals with relevant clinical sciences knowledge in (heart preferred) organ transplantation will be considered: Pharm D, PhD, or MD
Prior experience in MSL role highly preferred and/or the introduction of new clinical laboratory tests preferred
3-5 plus years of work experience in transplantation, cardiology and/or immunology
Outstanding oral presentation skills with a portfolio to support
Publication Portfolio
Ability to explain how AlloMap and AlloSure scores can be used and added to the milieu of other available clinical data, interpret clinical scenarios, and communicate diagnostic and management issues in transplant recipients
Experience in establishing strong, collaborative working relationships with clinicians
Experience in establishing strong, collaborative working relationships with internal stakeholder functions (e.g. Sales, Marketing, Regulatory, R&D) and external customers
Knowledge of molecular biology and immunology helpful
Outstanding interpersonal skills and collaborative work style
Benefits
Health and welfare benefits, including a gym reimbursement program
401(k) savings plan match
Employee Stock Purchase Plan
Pre-tax commuter benefits
Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow
Company
CareDx, Inc.
CareDx, Inc., headquartered in South San Francisco, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
501-1000 employees
H1B Sponsorship
CareDx, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (8)
2023 (4)
2022 (22)
2021 (21)
2020 (9)
Funding
Current Stage
Public CompanyTotal Funding
$574.89MKey Investors
Bristol-Myers SquibbSprout Group
2021-01-21Post Ipo Equity· $164M
2020-06-09Post Ipo Equity· $117.1M
2018-11-13Post Ipo Equity· $52.8M
Leadership Team
John Hanna
President and CEO
Nathan Smith
Chief Financial Officer
Recent News
2026-01-16
2026-01-14
Company data provided by crunchbase